Evidence map›Paper›PMID 41596859›Full record

ReviewFoods (Basel, Switzerland)2026

Print, Eat, Heal: Unravelling the Potential of Bioactives in 3D Food Technology.

Monize Bürck, Monica Masako Nakamoto, Sergiana Dos Passos Ramos, Marcelo Assis, Anna Rafaela Cavalcante Braga

Abstract readReview
In one paragraph

Review in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Monize BürckDepartment of Biosciences, Universidade Federal de São Paulo (UNIFESP), Santos 11015-020, Brazil.ORCID 0000-0002-5045-1518
Monica Masako NakamotoDepartment of Biosciences, Universidade Federal de São Paulo (UNIFESP), Santos 11015-020, Brazil.ORCID 0000-0002-2947-5128
Sergiana Dos Passos RamosDepartment of Biosciences, Universidade Federal de São Paulo (UNIFESP), Santos 11015-020, Brazil.ORCID 0000-0002-4823-1399
Marcelo AssisDepartment of Biosciences, Universidade Federal de São Paulo (UNIFESP), Santos 11015-020, Brazil.ORCID 0000-0003-0355-5565
Anna Rafaela Cavalcante BragaDepartment of Biosciences, Universidade Federal de São Paulo (UNIFESP), Santos 11015-020, Brazil.ORCID 0000-0002-7052-0226

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 001Fundação de Amparo à Pesquisa do Estado de São Paulo 2023/00857-0, 2022/06293-9, and 2020/06732-7National Council for Scientific and Technological Development 305518/2024-0
6 · The paper itself

Abstract

3D-printed food (3DPF) is on the rise, enabling the development of new food products. Current applications in this domain led to the replication of meat analogs, protein-enriched products, and dietary solutions tailored to address nuanced health necessities. Central to the functional versatility of 3DPF is its capacity for post-printing textural manipulation, which facilitates diverse food applications. Integrating bioactive compounds sourced from biodiversity, vegetables, algae, and agricultural residues is not merely an exercise in culinary refinement but an outstanding contribution to the circular economy. Strategic incorporation of these bioactive compounds into foodinks enhances the antioxidant potential of consumables and contributes to physiological benefits for human health, as evidenced by extant literature, which underscores their antioxidative and anti-inflammatory properties. Nevertheless, critical gaps emerge upon a meticulous examination of the recent literature, notably regarding the viability of bioactive compounds within foodink matrices for 3DPF and their bioaccessibility after simulated digestion. Thus, the objective of this review is to evaluate the current state of the art in 3DPF, with a focus on biodiversity as a source of innovative ingredients and matrices and on the bioaccessibility of associated bioactive compounds, while outlining future research directions in this field.

Indexed as

3D technologiesantioxidant activitybioaccessibilityfood industryinnovative ingredients

Identifiers

PMID41596859
PMCPMC12840433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.